TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer

European Journal of Cancer

Volumn 47, Issue 8, 2011, Pages 1203-1210

  Castro, F A ^a   Forsti A ^a,b   Buch, S ^c   Kalthoff, H ^c   Krauss, C ^c   Bauer, M ^c   Egberts, J ^c   Schniewind, B ^c   Broering, D C ^c   Schreiber, S ^c   Schmitt, M ^a   Hampe, J ^c   Hemminki, K ^a,b   Schafmayer, C ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Alimentary tract; Prognosis and survival; Variants

Indexed keywords

INTERLEUKIN 10; TOLL LIKE RECEPTOR 3;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDEPENDENT VARIABLE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GERMANY; HUMANS; INTERLEUKIN-10; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; TOLL-LIKE RECEPTOR 3;

EID: 79955531832     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.12.011     Document Type: Article

References (36)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2 2005 74 108 (Pubitemid 40372904)
2. D. Cunningham, W. Atkin, and H.J. Lenz Colorectal cancer Lancet 375 9719 2010 1030 1047
3. R. Nauta, D.M. Stablein, and E.D. Holyoke Survival of patients with stage B2 colon carcinoma. The Gastrointestinal Tumor Study Group experience Arch Surg 124 2 1989 180 182 (Pubitemid 19059741)
4. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 19 2004 1420 1425 (Pubitemid 39429665)
5. B. Vicuna, and A.B. Benson 3rd Adjuvant therapy for stage II colon cancer: prognostic and predictive markers J Natl Compr Canc Netw 5 9 2007 927 936 (Pubitemid 350069531)
6. Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138(6):2101-14.e5.
7. A.M. Westbrook, A. Szakmary, and R.H. Schiestl Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models Mutat Res 705 1 2010 40 59
8. B. Frank, M. Hoffmeister, and N. Klopp Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk Int J Cancer 2010
9. S. Wilkening, B. Tavelin, and F. Canzian Interleukin promoter polymorphisms and prognosis in colorectal cancer Carcinogenesis 29 6 2008 1202 1206 (Pubitemid 351964881)
10. N. Mockelmann, W. von Schonfels, and S. Buch Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer BMC Gastroenterol 9 2009 79
11. M. Krawczak, S. Nikolaus, and H. von Eberstein PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships Commun Genet 9 1 2006 55 61 (Pubitemid 43289519)
12. B. Salaun, I. Coste, M.C. Rissoan, S.J. Lebecque, and T. Renno TLR3 can directly trigger apoptosis in human cancer cells J Immunol 176 8 2006 4894 4901
13. M.J. Gunter, F. Canzian, and S. Landi Inflammation-related gene polymorphisms and colorectal adenoma Cancer Epidemiol Biomarkers Prev 15 6 2006 1126 1131
14. A. Hadinia, S.V. Hossieni, and N. Erfani CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers J Gastroenterol Hepatol 22 12 2007 2283 2287 (Pubitemid 350145629)
15. F.A. Castro, K. Haimila, and I. Sareneva Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population - a candidate gene approach Int J Cancer 125 8 2009 1851 1858
16. M. Schmitt, I.G. Bravo, and P.J. Snijders Bead-based multiplex genotyping of human papillomaviruses J Clin Microbiol 44 2 2006 504 512 (Pubitemid 43222244)
17. The International HapMap Project Nature 426 6968 2003 789 796
18. A. Sobrero Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposal Lancet Oncol 7 6 2006 515 516
19. H. Oshiumi, M. Matsumoto, K. Funami, T. Akazawa, and T. Seya TICAM-1, an adaptor molecule that participates in toll-like receptor 3-mediated interferon-beta induction Nat Immunol 4 2 2003 161 167 (Pubitemid 36193018)
20. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 6857 2001 732 738 (Pubitemid 33009951)
21. M. Schroder, and A.G. Bowie TLR3 in antiviral immunity: key player or bystander? Trends Immunol 26 9 2005 462 468 (Pubitemid 41139255)
22. S. Rakoff-Nahoum, and R. Medzhitov Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88 Science 317 5834 2007 124 127 (Pubitemid 47056471)
23. S.H. Rhee, E. Im, and C. Pothoulakis Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer Gastroenterology 135 2 2008 518 528
24. T. Boraska Jelavic, M. Barisic, and I. Drmic Hofman Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer Clin Genet 70 2 2006 156 160 (Pubitemid 44028102)
25. J. Lacour, F. Lacour, and B. Ducot Therapeutic trial of poly(A). Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results Chirurgie 114 6 1988 516 523 (Pubitemid 19047725)
26. D.M. Lim, S. Narasimhan, C.Z. Michaylira, and M.L. Wang TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells Am J Physiol Gastrointest Liver Physiol 297 6 2009 G1172 G1180
27. J.K. Bell, I. Botos, and P.R. Hall The molecular structure of the toll-like receptor 3 ligand-binding domain Proc Natl Acad Sci USA 102 31 2005 10976 10980 (Pubitemid 41105978)
28. J. Sun, K.E. Duffy, and C.T. Ranjith-Kumar Structural and functional analyses of the human toll-like receptor 3. Role of glycosylation J Biol Chem 281 16 2006 11144 11151 (Pubitemid 43855539)
29. A. Laplanche, L. Alzieu, and T. Delozier Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer: a 14 year follow-up analysis of a randomized trial of the Federation Nationale des Centres de Lutte contre le Cancer (FNCLCC) Breast Cancer Res Treat 64 2 2000 189 191 (Pubitemid 32010336)
30. M. Taura, R. Fukuda, and M.A. Suico TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis Cancer Sci 101 7 2010 1610 1617
31. E. Crawley, R. Kay, and J. Sillibourne Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 42 6 1999 1101 1108 (Pubitemid 29268946)
32. A. Suarez, P. Castro, R. Alonso, L. Mozo, and C. Gutierrez Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms Transplantation 75 5 2003 711 717 (Pubitemid 36337373)
33. C.S. McArdle, and D.J. Hole Influence of volume and specialization on survival following surgery for colorectal cancer Br J Surg 91 5 2004 610 617 (Pubitemid 38624671)
34. S.K. Wong, B.B. Jalaludin, and M.J. Morgan Tumor pathology and long-term survival in emergency colorectal cancer Dis Colon Rectum 51 2 2008 223 230
35. J. Green, J. Watson, M. Roche, V. Beral, and J. Patnick Stage, grade and morphology of tumours of the colon and rectum recorded in the Oxford Cancer Registry, 1995-2003 Br J Cancer 96 1 2007 140 142 (Pubitemid 46094652)
36. V.P. Doria-Rose, T.R. Levin, and J.V. Selby The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval Gastroenterology 127 3 2004 714 722 (Pubitemid 39208404)